Pharmacokinetics and safety of highly variable nitroglycerin lingual spray (NLS) versus US-licensed nitroglycerin lingual spray reference product (Nitrolingual®): a randomized, four-cycle, four-sequence, partially replicated crossover Phase I bioequivalence clinical trial
Yingying Fang(Capital Medical University), Xinghe Wang(Capital Medical University), H. Liu(Capital Medical University), Xiaoqiang Cheng(Capital Medical University), Yingjuan Zhang(Capital Medical University), Long Liu(Capital Medical University), Yu Wang(Capital Medical University), Qian Zhang(Huazhong Agricultural University), Yan Li(University of Michigan), Ju Liu(Shandong First Medical University), Mingli Sun(Capital Medical University), Pu Li(Capital Medical University), Xiaoyun Liu(Capital Medical University), Yinjuan Li(Capital Medical University), Chunyu Han(Hangzhou DAC Biotech (China)), Lu Qi(Capital Medical University)
Cited by 0
Related Papers
Biodegradable Lipids Enabling Rapidly Eliminated Lipid Nanoparticles for Systemic Delivery of RNAi Therapeutics
|Molecular Therapy|2013|617
Global, regional, and national burden of thalassemia, 1990–2021: a systematic analysis for the global burden of disease study 2021
|EClinicalMedicine|2024|278
Blood neuro‐exosomal synaptic proteins predict Alzheimer's disease at the asymptomatic stage
|Alzheimer s & Dementia|2020|256
Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis
|Stem Cell Research & Therapy|2021|248
ULK1-mediated metabolic reprogramming regulates Vps34 lipid kinase activity by its lactylation
|Science Advances|2023|206